Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus on blood volume analysis and the company’s commercialization plans following FDA clearance of a new portable analyzer. President and Chief Executive Officer Michael Feldschuh described Daxor as a radiopharmaceutical diagnostic company with a “razor-and-blades” revenue […]